A cosmetics business may formulate products, commission a manufacturer or sell goods under its own brand. The insurance enquiry should make that relationship clear and identify how ingredients and product information are controlled.
Products and supply-chain responsibility
Product liability and product recall should be assessed separately. Claims concerning injury or damage, replacing defective goods and organising a withdrawal can have different triggers and exclusions. Describe the business’s role in the supply chain.
The decision that deserves the closest review
Describe formulation responsibility, testing records, labelling approvals and distribution territories. Ask how outsourced manufacturing, own-brand status and online exports affect the proposed terms. Compare recall and stock cover separately where those costs matter.
Premiums, excesses and usable cover
Request quotations using the same business description, required limits and relevant dates. Put the annual premium, any instalment charges, excesses and important sublimits in one comparison. A cheaper premium can represent a different transfer of risk rather than the same cover at a better price.
| Comparison item | Question to resolve |
|---|---|
| Formulation and manufacturing arrangements | Are all product categories accepted? |
| Product information and testing records | How is outsourced manufacture described? |
| Online sales and overseas destinations | Which territories and product claims are excluded? |
Request the proposed wording and schedule, not just a price or certificate. Mark any difference that affects a real activity before deciding whether the premium saving is worthwhile.
A hypothetical example
A brand adds a new skincare range produced by a different supplier. It provides the insurer with product details and the new quality-control arrangement instead of assuming the old beauty-products description is sufficient.
Prepare an accurate insurance enquiry
Give each adviser a consistent description of the activities being insured. Include important contracts, changes since the previous enquiry and matters the insurer asks you to disclose. Do not guess answers merely to obtain a faster or cheaper quote; ask for clarification when the proposal wording is unclear.
Describe formulation, branding and sales channels together
A cosmetics brand should show who formulates, manufactures, labels and distributes its products. Include own-brand goods and products supplied by others. Explain where customers buy them and which destinations are served, so a quotation is not based only on the location of the brand’s office.
Compare a customer allegation with a decision to remove a batch from sale. Ask about each relevant policy section, specialist exclusions and the records expected during notification. Review the proposal when ingredients, manufacturing partners or sales territories change rather than assuming the existing description still fits.
Include overseas work or sales in the UK business’s enquiry and confirm the accepted territories and jurisdictions.
A mistake to avoid
Using a broad cosmetics label without disclosing materially different products or sourcing arrangements.
Check what happens after the policy starts
Ask who to contact when activities change or a potential claim arises. Understand the notification and consent process before arranging repairs, appointing specialists or settling a complaint. At renewal, compare the new documents with the accepted business description; continuity of a familiar brand does not prove continuity of every term.
Questions before choosing
Is a contract manufacturer’s insurance enough?
Check the brand’s retained obligations and any recovery rights; another party’s policy does not necessarily remove the brand’s exposure.
Does insurance establish that a product is suitable for sale?
Product compliance and insurance are separate reviews. Obtain the relevant specialist support and compare insurance against the goods and activities actually involved.
Sources and further reading
Research date: 6 October 2026. Refer to the current linked guidance and written provider or adviser terms when making a decision.